Literature DB >> 779998

Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.

R Ganguly, L W Clem, Z Bencić, R Sinha, R Sakazaki, R H Waldman.   

Abstract

The efficacy of various cholera vaccines in eliciting an intestinal antibody response was assessed in human volunteers who received oral live, oral killed, or parenteral cholera vaccines, or placebo. The intestinal immune response in terms of antibacterial and antitoxin antibodies was determined 2 and 4 weeks after immunization. By means of the mouse peritoneum opsonization assay and the infant mouse protection test, antibacterial activity could be detected in the intestinal secretions of volunteers who had been immunized either orally or by the parenteral route. Significant protective activity and duration of immunity were observed with the oral killed vaccine. The bacteriological data indicated the absence of significant intestinal colonization of the live attenuated strain after oral administration, and probably explains the observed lack of effectiveness of the oral vaccine compared with that of the killed vaccine. The predominant immunoglobulin class of intestinal antibody was found to be IgA. None of the vaccines used in the study elicited significant antitoxin activity in the intestinal secretions, as determined by the skin permeability neutralization test.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 779998      PMCID: PMC2366383     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  17 in total

1.  INTESTINAL MORPHOLOGY IN HUMAN AND EXPERIMENTAL CHOLERA.

Authors:  J W FRESH; P M VERSAGE; V REYES
Journal:  Arch Pathol       Date:  1964-05

2.  ORAL IMMUNIZATION AND PRODUCTION OF COPROANTIBODY IN HUMAN VOLUNTEERS.

Authors:  R FRETER; E J GANGAROSA
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

3.  Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

4.  Protection against enteric bacterial infection by secretory IgA antibodies.

Authors:  E S Fubara; R Freter
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

5.  Live oral cholera vaccine: report of a trial on human volunteer subjects.

Authors:  S C Sanyal; S Mukerjee
Journal:  Bull World Health Organ       Date:  1969-04       Impact factor: 9.408

6.  Bacteriological studies of convalescent carriers of cholera vibrios.

Authors:  N F Pierce; J C Banwell; S L Gorbach; R C Mitra; A Mondal; P M Manji
Journal:  Indian J Med Res       Date:  1969-04       Impact factor: 2.375

7.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

8.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

9.  Detection of Vibrio cholerae biotype El Tor by purging.

Authors:  E J Gangarosa; H Saghari; J Emile; H Siadat
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  Mechanism of Action of Intestinal Antibody in Experimental Cholera II. Antibody-Mediated Antibacterial Reaction at the Mucosal Surface.

Authors:  R Freter
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

View more
  7 in total

Review 1.  Killed oral cholera vaccines: history, development and implementation challenges.

Authors:  Anna Lena Lopez; Maria Liza Antoinette Gonzales; Josephine G Aldaba; G Balakrish Nair
Journal:  Ther Adv Vaccines       Date:  2014-09

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.

Authors:  D Cohen; N Orr; G Robin; R Slepon; S Ashkenazi; I Ashkenazi; J Shemer
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  Guinea pig lung lavage cells after intranasal BCG sensitization.

Authors:  T Terai; R Ganguly; R H Waldman
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

5.  Immune response of the ileum to invasive Escherichia coli diarrheal disease in rabbits.

Authors:  P D O'Hanley; J R Cantey
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

Review 6.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

7.  Scalable production and immunogenicity of a cholera conjugate vaccine.

Authors:  Suhi Jeon; Meagan Kelly; Jeesun Yun; Byungman Lee; Minchul Park; Yoonhee Whang; Chankyu Lee; Yuan-Di Halvorsen; Smriti Verma; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Daniel T Leung; Taufiqur R Bhuiyan; Firdausi Qadri; Mohammad Kamruzzaman; Somyoung Cho; Willie F Vann; Peng Xu; Pavol Kováč; Ravi Ganapathy; Julia Lynch; Edward T Ryan
Journal:  Vaccine       Date:  2021-10-27       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.